titlesubmit dateissue date
Now showing items 1-7 of 7
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses.
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models.
Clonal dynamics in osteosarcoma defined by RGB marking
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Sarcoma treatment in the era of molecular medicine.
SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications